Moderate

CKD-mineral bone disorder (secondary & tertiary hyperparathyroidism)

CKD-MBD · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Disordered calcium, phosphate, vitamin D and PTH metabolism in chronic kidney disease, driving secondary (then autonomous tertiary) hyperparathyroidism, bone disease and vascular calcification.

Red flags

  • Severe hypercalcaemia (tertiary hyperparathyroidism)
  • Calciphylaxis (painful skin necrosis)
  • Pathological fracture
  • Rapidly rising PTH with symptoms
  • Extensive vascular/soft-tissue calcification

Assessment

Differential diagnosis

  • Primary hyperparathyroidism
  • Vitamin D deficiency osteomalacia
  • Adynamic bone disease
  • Malignancy-related bone disease
  • Osteoporosis

Investigations

  • Serum calcium, phosphate, PTH and alkaline phosphatase
  • 25-hydroxyvitamin D
  • eGFR and bicarbonate
  • Imaging/bone markers for calcification or fracture
  • Parathyroid ultrasound/sestamibi if tertiary disease suspected

Management

  • Monitor calcium, phosphate and PTH at CKD-stage-appropriate intervals
  • Control hyperphosphataemia with dietary phosphate restriction first
  • Add phosphate binders, preferring non-calcium binders where calcium load is a concern
  • Correct vitamin D deficiency with nutritional vitamin D
  • Use active vitamin D analogues for persistent PTH elevation (watch calcium/phosphate)
  • Add calcimimetics to lower PTH when still high despite the above
  • Avoid over-suppression causing adynamic bone disease
  • Consider parathyroidectomy for severe refractory or autonomous (tertiary) disease
  • Manage acidosis and overall cardiovascular risk

Drugs & doses

Sevelamer 800-1600 mg PO with meals (non-calcium binder)
Calcium acetate/carbonate with meals as binder/calcium source
Alfacalcidol or calcitriol low dose for PTH control
Cinacalcet 30 mg PO once daily (titrate) or IV etelcalcetide for dialysis patients

Disposition

Co-manage with nephrology; refer for parathyroidectomy in refractory tertiary disease and treat calciphylaxis urgently with multidisciplinary input.

Complications & pitfalls

  • Renal osteodystrophy and fractures
  • Vascular and valvular calcification
  • Calciphylaxis
  • Adynamic bone disease from over-treatment
  • Autonomous tertiary hyperparathyroidism needing surgery

Exam pearls

  • Control phosphate before chasing PTH; hyperphosphataemia drives the whole process
  • Avoid excess calcium-based binders and active vitamin D to limit calcification and adynamic bone
  • Persistent hypercalcaemia after transplant suggests tertiary disease needing parathyroidectomy
  • Calciphylaxis is a dermatological emergency with high mortality

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.